Abstact
Ginsenosides are active compounds isolated from Panax ginseng Meyer. Among these ginsenosides, less polar ginsenosides such as ginsenoside Rg3 and ginsenoside Rh2 have been demonstrated to have tumor inhibitory effects because of their cytotoxicity. In this study, we evaluated the apoptotic effects of ginsenoside Rk1 in SK-MEL-2 human melanoma. Ginsenoside Rk1 isolated from red ginseng is one of the novel ginsenosides that shows strong cytotoxicity compared to ginsenoside Rg3 in dose- and time-dependent manners. The results of DNA fragmentation, 4′,6-diamidino-2-phenylindole staining, and flow cytometric analysis are corroborated that ginsenoside Rk1 induced apoptosis in SK-MEL-2 cells. Western blot analysis revealed up-regulation of Fas, FasL, and Bax protein expression and down-regulation of procaspase-8, procaspase-3, mutant p53 and Bcl-2 protein expression. These findings suggest that ginsenoside Rk1 might be a promising compound to induce apoptosis through both extrinsic and intrinsic pathways in SK-MEL-2 cells.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Benchimol, S., p53-dependent pathways of apoptosis. Cell Death Differ., 8, 1049–1051 (2001).
Benjamin, C. L. and Ananthaswamy, H. N., p53 and the pathogenesis of skin cancer. Toxicol. Appl. Pharmacol., 224, 241–248 (2007).
Chen, J., Peng, H., Ou-Yang, X., and He, X., Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells. Melanoma Res., 18, 322–329 (2008).
Erb, P., Ji, J., Wernli, M., Kump, E., Glaser, A., and Buchner, S. A., Role of apoptosis in basal cell and squamous cell carcinoma formation. Immunol. Lett., 100, 68–72 (2005).
Ha, Y. W., Lim, S. S., Ha, I. J., Na, Y. C., Seo, J. J., Shin, H., Son, S. H., and Kim, Y. S., Preparative isolation of four ginsenosides from Korean red ginseng (steam-treated Panax ginseng C. A. Meyer), by high-speed counter-current chromatography coupled with evaporative light scattering detection. J. Chromatogr. A, 115, 137–144 (2007).
Kim, S. M., Lee, S. Y., Cho, J. S., Son, S. M., Choi, S. S., Yun, Y. P., Yoo, H. S., Yoon, D. D., Oh, K. W., Han, S. B., and Hong, J. T., Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. Eur. J. Pharmacol., 631, 1–9 (2010).
Kim, Y. J., Kwon, H. C., Ko, H., Park, J. H., Kim, H. Y., Yoo, J. H., and Yang, H. O., Anti-tumor activity of the ginsenoside Rk1 in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis. Biol. Pharm. Bull., 31, 826–830 (2008).
Latonen, L. and Laiho, M., Cellular UV damage responsesfunctions of tumor suppressor p53. Biochim. Biophys. Acta, 1755, 71–89 (2005).
Lee, J. G., Lee, Y. Y., Kim, S. Y., Pyo, J. S., Yun-Choi, H. S., and Park, J. H., Platelet antiaggregating activity of ginsenosides isolated from processed ginseng. Pharmazie, 64, 602–604 (2009).
Liu, T. G., Huang, Y., Cui, D. D., Huang, X. B., Mao, S. H., Ji, L. L., Song, H. B., and Yi, C., Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer, 9, 250 (2009).
O’Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S., and Mutoh, M., Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res., 57, 4285–4300 (1997).
Park, I. H., Kim, N. Y., Han, S. B., Kim, J. M., Kwon, S. W., Kim, H. J., Park, M. K., and Park, J. H., Three new dammarane glycosides from heat processed ginseng. Arch. Pharm. Res., 25, 428–432 (2002).
Sato, K., Mochizuki, M., Saiki, I., Yoo, Y. C., Samukawa, K., and Azuma, I., Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol. Pharm. Bull., 17, 635–639 (1994).
Stretch, J. R., Gatter, K. C., Ralfkiaer, E., Lane, D. P., and Harris, A. L., Expression of mutant p53 in melanoma. Cancer Res., 51, 5976–5979 (1991).
Vousden, K. H. and Lane, D. P., p53 in health and disease. Nat. Rev. Mol. Cell Biol., 8, 275–283 (2007).
Wallace-Brodeur, R. R. and Lowe, S. W., Clinical implications of p53 mutations. Cell. Mol. Life Sci., 55, 64–75 (1999).
Wang, C. Z., Aung, H. H., Zhang, B., Sun, S., Li, X. L., He, H., Xie, J. T., He, T. C., Du, W., and Yuan, C. S., Chemopreventive effects of heat-processed Panax quinquefolius root on human breast cancer cells. Anticancer Res., 28, 2545–2551 (2008).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, J.S., Joo, E.J., Chun, J. et al. Induction of apoptosis by ginsenoside Rk1 in SK-MEL-2-human melanoma. Arch. Pharm. Res. 35, 717–722 (2012). https://doi.org/10.1007/s12272-012-0416-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-012-0416-0